Showing results (661-670 of 1,609) with videos related to

Sort By:
Pageof 161
JAMA Oncology|April 1, 2021
Assessment of Pembrolizumab Therapy for the Treatment of Microsatellite Instability-High Gastric or Gastroesophageal Junction Cancer Among Patients in the KEYNOTE-059, KEYNOTE-061, and KEYNOTE-062 Clinical TrialsJoseph Chao, Charles S Fuchs, Kohei Shitara, et al.
JAMA Oncology|August 8, 2020
Perspectives on Oncology-Specific Language During the Coronavirus Disease 2019 Pandemic: A Qualitative StudyLaila A Gharzai, Kenneth Resnicow, Lawrence C An, et al.
JAMA Oncology|August 8, 2020
Applying Lessons Learned From Low-Resource Settings to Prioritize Cancer Care in a PandemicRebecca J DeBoer, Temidayo A Fadelu, Lawrence N Shulman, et al.
JAMA Oncology|August 21, 2020
Morbidity and Mortality of Laparoscopic vs Open Total Gastrectomy for Clinical Stage I Gastric Cancer: The CLASS02 Multicenter Randomized Clinical TrialFenglin Liu, Changming Huang, Zekuan Xu, et al.
JAMA Oncology|July 3, 2020
Characterization of the Cancer Spectrum in Men With Germline BRCA1 and BRCA2 Pathogenic Variants: Results From the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)Valentina Silvestri, Goska Leslie, Daniel R Barnes, et al.
JAMA Oncology|May 18, 2023
Risk of Syndrome-Associated Cancers Among First-Degree Relatives of Patients With Pancreatic Ductal Adenocarcinoma With Pathogenic or Likely Pathogenic Germline VariantsXuan Chen, Margaret A Meyer, Jennifer L Kemppainen, et al.
JAMA Oncology|May 18, 2023
Association of MGMT Promoter Methylation With Survival in Low-grade and Anaplastic Gliomas After Alkylating ChemotherapyConnor J Kinslow, Ann Mercurio, Prashanth Kumar, et al.
JAMA Oncology|April 15, 2021
Safety and Effectiveness of Weekly Carfilzomib, Lenalidomide, Dexamethasone, and Daratumumab Combination Therapy for Patients With Newly Diagnosed Multiple Myeloma: The MANHATTAN Nonrandomized Clinical TrialOla Landgren, Malin Hultcrantz, Benjamin Diamond, et al.
JAMA Oncology|May 11, 2023
Efficacy of Endocrine Therapy Plus Trastuzumab and Pertuzumab vs De-escalated Chemotherapy in Patients with Hormone Receptor-Positive/ERBB2-Positive Early Breast Cancer: The Neoadjuvant WSG-TP-II Randomized Clinical TrialOleg Gluz, Ulrike A Nitz, Matthias Christgen, et al.
JAMA Oncology|May 15, 2023
American Radium Society Appropriate Use Criteria for Radiation Therapy in the Multidisciplinary Management of Thymic CarcinomaStephen G Chun, Andreas Rimner, Arya Amini, et al.
Pageof 161